Cite Filings / ORKA / 9999999997-24-003613

Feed Companies Filings Check

Sign in

SEC STAFF LETTER

SEC Staff Letter Redacted Exhibit

Oruka Therapeutics, Inc. Filed 2024-07-12 Acc 9999999997-24-003613

Documents 1

SEC STAFF LETTER SEC Staff Letter Redacted Exhibit , filename1.pdf

Around this filing

2024-07-26 SEC STAFF LETTER SEC Staff Letter Redacted Exhibit
2024-07-12 SEC STAFF LETTER SEC Staff Letter Redacted Exhibit
2024-07-12 4 10% owner bought 408,777 shares at an average $3.49 ($1,427,345)
2024-07-12 3 Initial Statement of Ownership
2024-07-09 CORRESP Correspondence Between Filers and SEC Staff
2024-07-09 S-4/A Registration Statement - Business Combination
2024-07-09 425 Prospectus/Communication re Business Combination

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading filename1.pdf…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…